Iris Pharma and RxGen, Inc. Announce Strategic Alliance

NICE, France & HAMDEN, Conn.--(BUSINESS WIRE)--Iris Pharma, a leading ophthalmic preclinical and clinical contract research organization (CRO), and RxGen, a specialty preclinical CRO focused on the development and application of translational research models, have established a Strategic Alliance to offer fully integrated “bench-to-bedside” ophthalmology research services to the global pharmaceutical and biotechnology industries.

Back to news